{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:08Z","timestamp":1791357248842,"version":"4.3.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.mayocp.2012.05.015","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T06:02:23Z","timestamp":1344492143000},"page":"890-900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Treatment of Nightmares With Prazosin: A Systematic Review"],"prefix":"10.1016","volume":"87","author":[{"given":"Simon","family":"Kung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelde","family":"Espinel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I.","family":"Lapid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mayocp.2012.05.015_bib1","series-title":"Text Revision","article-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000"},{"issue":"4","key":"10.1016\/j.mayocp.2012.05.015_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5664\/jcsm.27883","article-title":"Best practice guide for the treatment of nightmare disorder in adults","volume":"6","author":"Aurora","year":"2010","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"10.1016\/j.mayocp.2012.05.015_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jsmc.2008.01.005","article-title":"Parasomnias: psychiatric considerations","volume":"3","author":"Plante","year":"2008","journal-title":"Sleep Med Clin"},{"issue":"8","key":"10.1016\/j.mayocp.2012.05.015_bib4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.biopsych.2006.06.032","article-title":"A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder","volume":"61","author":"Raskind","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"7","key":"10.1016\/j.mayocp.2012.05.015_bib5","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1176\/ajp.155.7.929","article-title":"Sleep disturbances in the Vietnam generation: findings from a nationally representative sample of male Vietnam veterans","volume":"155","author":"Neylan","year":"1998","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1016\/j.mayocp.2012.05.015_bib6","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0006-3223(00)00917-3","article-title":"Laboratory sleep correlates of nightmare complaint in PTSD inpatients","volume":"48","author":"Woodward","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mayocp.2012.05.015_bib7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"10.1016\/j.mayocp.2012.05.015_bib8","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1176\/appi.ajp.158.8.1227","article-title":"CSF norepinephrine concentrations in posttraumatic stress disorder","volume":"158","author":"Geracioti","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.mayocp.2012.05.015_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/01.pra.0000265763.79753.c1","article-title":"Pharmacologic reduction of CNS noradrenergic activity in PTSD: the case for clonidine and prazosin","volume":"13","author":"Boehnlein","year":"2007","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.mayocp.2012.05.015_bib10","series-title":"VA\/DoD Clinical Practice Guideline for Management of Post-Traumatic Stress","year":"2010"},{"issue":"4","key":"10.1016\/j.mayocp.2012.05.015_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/archgenpsychiatry.2008.536","article-title":"Tracing the flow of knowledge: geographic variability in the diffusion of prazosin use for the treatment of posttraumatic stress disorder nationally in the Department of Veterans Affairs","volume":"66","author":"Harpaz-Rotem","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mayocp.2012.05.015_bib12","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","year":"2011"},{"issue":"1","key":"10.1016\/j.mayocp.2012.05.015_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jts.2490080106","article-title":"The development of a Clinician-Administered PTSD Scale","volume":"8","author":"Blake","year":"1995","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.mayocp.2012.05.015_bib14","series-title":"ECDEU Assessment Manual for Psychopharmacology","year":"1976"},{"issue":"10","key":"10.1016\/j.mayocp.2012.05.015_bib15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.mayocp.2012.05.015_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/appi.ajp.160.2.371","article-title":"Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study","volume":"160","author":"Raskind","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.mayocp.2012.05.015_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.biopsych.2007.07.001","article-title":"Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study","volume":"63","author":"Taylor","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.mayocp.2012.05.015_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpsychores.2011.11.010","article-title":"Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US Military Veterans","volume":"72","author":"Germain","year":"2012","journal-title":"J Psychosom Res"},{"issue":"2","key":"10.1016\/j.mayocp.2012.05.015_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4088\/JCP.v61n0208","article-title":"The alpha1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of 4 cases","volume":"61","author":"Raskind","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.mayocp.2012.05.015_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00004714-200202000-00013","article-title":"The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder","volume":"22","author":"Taylor","year":"2002","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.mayocp.2012.05.015_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/0891988703256050","article-title":"Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder","volume":"16","author":"Peskind","year":"2003","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"5","key":"10.1016\/j.mayocp.2012.05.015_bib22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/jts.20570","article-title":"Prazosin treatment of trauma nightmares and sleep disturbance in soldiers deployed in Iraq","volume":"23","author":"Calohan","year":"2010","journal-title":"J Trauma Stress"},{"issue":"7","key":"10.1016\/j.mayocp.2012.05.015_bib23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4088\/JCP.v63n0705","article-title":"Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder","volume":"63","author":"Raskind","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.mayocp.2012.05.015_bib24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7205\/MILMED.170.6.513","article-title":"Clinical case series: the use of Prazosin for combat-related recurrent nightmares among Operation Iraqi Freedom combat veterans","volume":"170","author":"Daly","year":"2005","journal-title":"Mil Med"},{"issue":"4","key":"10.1016\/j.mayocp.2012.05.015_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jts.20351","article-title":"Nonnightmare distressed awakenings in veterans with posttraumatic stress disorder: response to prazosin","volume":"21","author":"Thompson","year":"2008","journal-title":"J Trauma Stress"},{"issue":"6","key":"10.1016\/j.mayocp.2012.05.015_bib26","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/01.pra.0000364287.63210.92","article-title":"Preliminary findings concerning the use of prazosin for the treatment of posttraumatic nightmares in a refugee population","volume":"15","author":"Boynton","year":"2009","journal-title":"J Psychiatr Pract"},{"issue":"11","key":"10.1016\/j.mayocp.2012.05.015_bib27","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/jclp.20730","article-title":"Treatment of nightmares in the context of posttraumatic stress disorder","volume":"66","author":"Gehrman","year":"2010","journal-title":"J Clin Psychol"},{"issue":"5","key":"10.1016\/j.mayocp.2012.05.015_bib28","first-page":"E5","article-title":"Treatment of insomnia in posttraumatic stress disorder","volume":"34","author":"Coupland","year":"2009","journal-title":"J Psychiatry Neurosci"},{"issue":"5","key":"10.1016\/j.mayocp.2012.05.015_bib29","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1176\/appi.ajp.2008.08111697","article-title":"Chest pain in a young patient treated with prazosin for PTSD","volume":"166","author":"Nuzhat","year":"2009","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.mayocp.2012.05.015_bib30","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1176\/appi.ajp.2008.07111710","article-title":"Bizarre behavior in a patient treated with prazosin for PTSD","volume":"165","author":"Reardon","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.mayocp.2012.05.015_bib31","first-page":"758","article-title":"Case report: use of prazosin for treatment of posttraumatic stress disorder","volume":"72","author":"Griffith","year":"2005","journal-title":"Am Fam Physician"},{"issue":"12","key":"10.1016\/j.mayocp.2012.05.015_bib32","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1345\/aph.1Q548","article-title":"Successful treatment of posttraumatic stress disorder with prazosin in a young child","volume":"45","author":"Strawn","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.mayocp.2012.05.015_bib33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/cap.2009.0002","article-title":"Prazosin for the treatment of posttraumatic stress disorder-related nightmares in an adolescent male","volume":"19","author":"Fraleigh","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"5","key":"10.1016\/j.mayocp.2012.05.015_bib34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/cap.2009.0043","article-title":"Prazosin treatment of an adolescent with posttraumatic stress disorder","volume":"19","author":"Strawn","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"10.1016\/j.mayocp.2012.05.015_bib35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/01.CHI.0000052509.98293.97","article-title":"Prazosin in PTSD","volume":"42","author":"Brkanac","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.mayocp.2012.05.015_bib36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/JCP.0b013e3181dac52f","article-title":"Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans: an assessment of long-term comparative effectiveness and safety","volume":"30","author":"Byers","year":"2010","journal-title":"J Clin Psychopharmacol"},{"issue":"9","key":"10.1016\/j.mayocp.2012.05.015_bib37","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1682\/JRRD.2009.05.0062","article-title":"Improving sleep: initial headache treatment in OIF\/OEF veterans with blast-induced mild traumatic brain injury","volume":"46","author":"Ruff","year":"2009","journal-title":"J Rehab Res Dev"},{"issue":"5","key":"10.1016\/j.mayocp.2012.05.015_bib38","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/10673229.2011.614483","article-title":"The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on posttraumatic stress disorder","volume":"19","author":"Bajor","year":"2011","journal-title":"Harvard Rev Psychiatry"},{"issue":"2","key":"10.1016\/j.mayocp.2012.05.015_bib39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pnpbp.2008.12.004","article-title":"Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review","volume":"33","author":"Berger","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.mayocp.2012.05.015_bib40","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1592\/phco.28.5.656","article-title":"Prazosin for the treatment of posttraumatic stress disorder sleep disturbances","volume":"28","author":"Miller","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.mayocp.2012.05.015_bib41","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neuropharm.2011.02.029","article-title":"Treating nightmares and insomnia in posttraumatic stress disorder: a review of current evidence","volume":"62","author":"Nappi","year":"2012","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.mayocp.2012.05.015_bib42","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2146\/ajhp070124","article-title":"Prazosin for treatment of nightmares related to posttraumatic stress disorder","volume":"65","author":"Taylor","year":"2008","journal-title":"Am J Health Syst Pharm"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619612006672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619612006672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:33:46Z","timestamp":1675902826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619612006672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0025619612006672"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2012.05.015","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Nightmares With Prazosin: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2012.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}